EP0893988A1 - Extrakt aus dem samenkorn von amarant und dieses enthaltende hautkosmetische zusammensetzung - Google Patents

Extrakt aus dem samenkorn von amarant und dieses enthaltende hautkosmetische zusammensetzung

Info

Publication number
EP0893988A1
EP0893988A1 EP97915521A EP97915521A EP0893988A1 EP 0893988 A1 EP0893988 A1 EP 0893988A1 EP 97915521 A EP97915521 A EP 97915521A EP 97915521 A EP97915521 A EP 97915521A EP 0893988 A1 EP0893988 A1 EP 0893988A1
Authority
EP
European Patent Office
Prior art keywords
extract
amaranth
water
solvent
seeds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP97915521A
Other languages
English (en)
French (fr)
Inventor
Bernard Fabre
Michel Jeanjean
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA filed Critical Pierre Fabre Dermo Cosmetique SA
Publication of EP0893988A1 publication Critical patent/EP0893988A1/de
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Definitions

  • the present invention relates to a cosmetic composition
  • a cosmetic composition comprising an amaranth extract, softening and hydrating.
  • Amaranth is an ornamental plant, family Amaranthaceae, belonging to the order of Chenopodiales with red flowers grouped in long clusters also called “fox tail” or "velvet pass”. Amaranth seeds were used as the main source of food by the Aztecs. Amaranth was also cultivated by the Incas, Mayans and other peoples of the pre-Columbian era. It is used today in India, in Latin American countries and also in a popcorn form and as a breakfast cereal in the United States (crackers, cookies, breads, cakes, pancakes and waffles).
  • the whole family of Amaranthaceae represents around 800 species of annual or permanent herbs.
  • Amaranth grows in single or multiple branches and can reach 1.50 m high.
  • the leaves are simple, with a pungent tip and cuneiform base.
  • the very small flowers are colored red-brown, grouped in axial panicle. They have 5 sepals, 5 stamens, 3 carpels.
  • the fruit is an achene.
  • the seeds are very small, less than 2 mm in diameter.
  • the seeds are composed of carbohydrates, 55 to 70%, lipids, 5 to 8%, fibers, 5 to 8%, proteins, 13 to 17%, minerals, 2 to 3%.
  • Carbohydrates are made up of simple sugars and starch. Sucrose is the most abundant simple sugar; it is accompanied by raffinose and maltose.
  • Starch is the most abundant component. This starch is special and gives amaranth its cosmetic properties. It constitutes very small granules. It is mainly composed of amylopectinc, so is degraded very quickly by amylases.
  • the proteins of amaranth seeds are more abundant than in cereals and are mainly composed of soluble proteins: albumins and globulincs. These are easily extracted.
  • the amino acid composition of these proteins is very interesting. Indeed, we find a high level of lysine and sulfur amino acids higher than other cereal seeds and the rest of the composition approaches the quality of animal protein.
  • the fat content of amaranth seeds has been studied.
  • the latter contain 8% on average, higher than cereals (2% in wheat).
  • the fatty acid composition highlights the richness in unsaturated fatty acids, AGE, over 70%.
  • gamma linolenic acid is present at a concentration greater than 1%.
  • the total mineral content (ash) in the seeds of amaranth species is generally higher than in other cereal seeds.
  • Properly ground amaranth flour contains 10 times more iron, 7 times more calcium and 4 times more zinc than commercial wheat flour.
  • Amaranth seeds have a high concentration of calcium (201-308 mg / 100 g) and iron (15-11 1 mg / 100 g).
  • the calcium level of amaranth seeds is higher than that of milk. Few studies provide information on bioavailability or the choice of the best food to provide this calcium in an easily assimilated form.
  • Amaranth seeds have a different vitamin concentration than that of wheat. It is higher for riboflavin and ascorbic acid, and lower for thiamine and niacin.
  • the present invention therefore relates firstly to an extract of amaranth seeds, useful in dermo-cosmetics for its softening and moisturizing properties.
  • This extract can be obtained by extracting the seeds, optionally ground or flattened, with an appropriate solvent, at a temperature between room temperature and the boiling point of the solvent, then by recovery of the liquid phase, which is then treated appropriately to obtain an aqueous solution of amaranth extract.
  • This solution can then be stabilized and / or sterilized, or the solvent can be evaporated until a dry, solid, powdery amaranth extract is obtained.
  • the appropriate solvent is advantageously chosen from water, C 1 -C 4 aliphatic alcohols, acetone, or mixtures thereof in all proportions, in particular water / acetone or water / alcohol mixtures, in proportions varying from 0 100% acetone or alcohol.
  • the weight ratio of amaranth seed / solvent can advantageously be between 1/5 and 1/20.
  • the extraction time is preferably between 1 hour and 24 hours.
  • the solid / liquid separation is carried out by filtration, spinning or decantation.
  • the extraction solvent consists of alcohol and / or acetone
  • the liquid extract obtained is treated by the addition of an appropriate quantity of water.
  • the organic solvents, alcohol and acetone are then evaporated, in particular under vacuum, until an aqueous solution is obtained.
  • This operation of adding an appropriate volume of water may be optional when the extraction solvent is water or a water / alcohol or water / acetone mixture.
  • the aqueous solution containing the amaranth extract can be sterilized or stabilized by the addition of a solvent such as propylene glycol, glycerin, transcutol, a microbial preservative, a gelling agent of the polysaccharide type.
  • a solvent such as propylene glycol, glycerin, transcutol, a microbial preservative, a gelling agent of the polysaccharide type.
  • Drying can also be carried out until a powder is obtained.
  • Amaranth extracts are characterized by the presence of a whitish precipitate obtained by the addition of ethanol, a precipitate which reflects the presence of polymer such as starch and proteins. Thin layer chromatography identifies the presence of amino acids and simple sugars. Finally, carbohydrates, simple sugars and starch can be determined by the anthrone reagent technique. Their content is between 1 and 50% compared to the dry matter.
  • the present invention also relates to dermo-cosmetic compositions comprising an amaranth extract defined above.
  • compositions can be presented in the form of shampoo, gel, foam, cream, etc., for topical application.
  • it is a gel useful for showering the body and the hair.
  • compositions according to the invention advantageously comprise between 0.5 and 10% by weight of amaranth extract, more advantageously between 1 and 5% by weight.
  • the composition according to the invention also comprises the usual components of dermo-cosmetic compositions, such as anionic, nonionic, cationic or amphoteric surfactants, stabilizing agents, gelling agents, volumizers, detanglers, viscosants, preservatives, protein extracts , perfumes, dyes, etc.
  • dermo-cosmetic compositions such as anionic, nonionic, cationic or amphoteric surfactants, stabilizing agents, gelling agents, volumizers, detanglers, viscosants, preservatives, protein extracts , perfumes, dyes, etc.
  • the compositions according to the invention comprise:
  • compositions according to the invention comprise:. 1 to 5% of amaranth extract,. 5 to 10% of surfactants,. 1 to 4% of protein extracts,. 1 to 3% viscosifiers, and. 65 to 80% water. They can also comprise from 0.1 to 0.5% of superfatting agents, such as for example triglycerides.
  • Protein extracts are in particular lipoproteins, glycoproteins or hydrolysates of proteins of animal or vegetable origin.
  • Detangling agents are in particular gums of plant origin such as guar gum, or cationic silicone emulsions.
  • the viscosifiers are in particular amides such as cocamide diethanolamine.
  • the volumizing agents are in particular cationic polymers.
  • This activity is sought on an aqueous extract of amaranth titrating 35% in carbohydrate compared to its dry matter.
  • the evaluation method is based on an electrical measurement. Water can indeed be considered as an electric dipole capable of driving electricity. The transport of electricity in a given field is proportional to the amount of water present in the stratum corneum.
  • the corneometric measurements concerning the amaranth extract were made in eight subjects at the level of the forearm.
  • the hydration indices were noted every 5 minutes for the 15 minutes following the application of the amaranth extract and then every 15 minutes for 2 hours 30 minutes.
  • the hydrating effects of the amaranth extract appear from the first 15 minutes and remain constant for 2 hours 30 minutes. There is a differential of 25% compared to the control.
  • the two groups note the sensations of softness, hydration of the scalp but also the disentangling, the volume and the heaviness of the hair.
  • the shampoo containing the amaranth extract is noted softening by "people of the first group and 8 people of the second.
  • the sensation of the hydrated scalp is also noted by 7 people of the two groups, the qualities of disentangling and volume being located at same level for both products.
  • Oleth 20 (water solubilizer)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
EP97915521A 1996-03-21 1997-03-20 Extrakt aus dem samenkorn von amarant und dieses enthaltende hautkosmetische zusammensetzung Ceased EP0893988A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9603510A FR2746303B1 (fr) 1996-03-21 1996-03-21 Extrait de graines d'amarante et composition dermo-cosmetique le comprenant
FR9603510 1996-03-21
PCT/FR1997/000489 WO1997034579A1 (fr) 1996-03-21 1997-03-20 Extrait de graines d'amarante et composition dermo-cosmetique le comprenant

Publications (1)

Publication Number Publication Date
EP0893988A1 true EP0893988A1 (de) 1999-02-03

Family

ID=9490384

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97915521A Ceased EP0893988A1 (de) 1996-03-21 1997-03-20 Extrakt aus dem samenkorn von amarant und dieses enthaltende hautkosmetische zusammensetzung

Country Status (3)

Country Link
EP (1) EP0893988A1 (de)
FR (1) FR2746303B1 (de)
WO (1) WO1997034579A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1145709A1 (de) * 2000-04-14 2001-10-17 Laboratoires Serobiologiques Verwendung von Naturstoffen zur Herstellung von kosmetischen Zubereitungen
FR2820744B1 (fr) 2001-02-14 2003-04-11 Oreal Nouveaux pyrazolo-triazoles et utilisation de ces composes pour la teinture de fibres keratiniques
FR2822683B1 (fr) 2001-03-30 2005-01-28 Oreal Compositions cosmetiques contenant un phosphate d'amidon et un polymere cationique et leurs utilisations
DE102005038359A1 (de) * 2005-08-11 2007-02-15 Henkel Kgaa Amaranthsamenöl in Haarbehandlungsmitteln
FR2904545B1 (fr) * 2006-08-03 2013-01-18 Soc Extraction Principes Actif Utilisation d'un extrait d'amarante en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
WO2008015341A2 (fr) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait vegetal en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485692A (de) * 1966-10-19 1970-02-15 Rohto Pharma Verfahren zur Herstellung von Inokosteron und/oder Isoinokosteron für nicht therapeutische Zwecke
JPS63192705A (ja) * 1987-02-05 1988-08-10 Shiseido Co Ltd 皮膚外用剤
RU2041232C1 (ru) * 1992-07-28 1995-08-09 Институт органической и физической химии им.А.Е.Арбузова Способ получения рутина
JP3449759B2 (ja) * 1993-10-19 2003-09-22 同和鉱業株式会社 美白化粧料
JPH0812549A (ja) * 1994-06-29 1996-01-16 Shiseido Co Ltd 皮膚外用剤
JPH0899889A (ja) * 1994-08-02 1996-04-16 Taisho Pharmaceut Co Ltd アトピー性皮膚炎治療剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9734579A1 *

Also Published As

Publication number Publication date
WO1997034579A1 (fr) 1997-09-25
FR2746303B1 (fr) 1998-06-12
FR2746303A1 (fr) 1997-09-26

Similar Documents

Publication Publication Date Title
EP1001740B1 (de) Verwendung von ginsenoside rb1 zur stimulierung der elastinsynthese
WO2003053383A2 (fr) Utilisation cosmetique d’au moins une hydrophobine pour le traitement des matieres keratiniques
EP2277502A2 (de) Verwendung pflanzlicher Extrakten um die Haut je nach ihrem Phototyp zu färben
FR3076460A1 (fr) Utilisation cosmetique d'un extrait proteique des graines de moringa oleifera
EP3113850B1 (de) Hautaufhellende kosmetikzusammensetzung
JP3330961B2 (ja) 皮膚改善剤
EP0977550B1 (de) Verwendung von mindestens einem irvingia gabonensis-extrakt in kosmetischen und/oder pharmazeutischen produkten
WO2022069844A1 (fr) Nouvelle utilisation d'un peptide pour améliorer le confort de la peau et/ou des muqueuses et/ou l'apparence des phanères
JPH0419962B2 (de)
EP1707191A2 (de) Verwendung pflanzlicher Extrakten um die Haut je nach ihrem Phototyp zu färben
EP0973494A1 (de) Verwendung eines adansonia-gattung extraktes
FR3112953A1 (fr) Utilisation cosmétique du sacran
WO2005105030A1 (fr) Composition cosmetique a base d'extrait de boutons floraux de caprier
WO1997034579A1 (fr) Extrait de graines d'amarante et composition dermo-cosmetique le comprenant
JPS60246305A (ja) 化粧料
EP2931232B1 (de) Kosmetische verwendung der kombination aus johannisbrotkeimextrakten und koffein als schlankheitswirkstoff
FR2880278A1 (fr) Utilisation d'huile et de proteines extraites de graines de plukenetia volubilis linneo dans des preparations cosmetiques, dermatologiques et nutraceutiques
JP2004149729A (ja) 抗酸化剤
FR3055214A1 (fr) Composition cosmetique eclaircissante
WO2018178604A1 (fr) Compositions cosmétiques comprenant une association d'ingrédients et leurs utilisations
KR20200048225A (ko) 화합물 수득 방법
EP0754448B1 (de) Mittel in Form eines in Wasser selbstemulgierenden Pulver
WO2019077268A1 (fr) Composition cosmétique de prévention active des signes de l'âge
WO2014029948A2 (fr) Extrait de lin et composition cosmetique comprenant ledit extrait pour augmenter le niveau de coenzyme q10 intracellulaire
JP2000109420A (ja) 老化用の化粧料

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19981012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH ES IT LI LU MC PT

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

17Q First examination report despatched

Effective date: 20010514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20011118